转自：天宇股份

作为全球制药供应链领域最具影响力的行业盛会之一，DCAT Week将于2025年3月17-20日(当地时间)再度登陆纽约。连续多年闪耀国际舞台的天宇药业，将携国际化营销团队深度参与本届盛会，与全球合作伙伴共探医药产业新机遇。

As one of the premier pharmaceutical supply chain event hosted annually by DCAT in New York, DCAT Week brings together global leaders across the bio/pharma value chain from 17th-20th March, 2025(local time). Tianyu Pharm, a returning exhibitor at this global platform, will showcase its international business capabilities while exploring new growth frontiers with worldwide partners.

诚邀您莅临本杰明皇家酒店609-610会客室，与我们开展战略对话：  

• 原料药创新解决方案  

• 定制化一站式CDMO服务 

• 全球化市场布局

Visit our suite at:  

THE BENJAMIN ROYAL SONESTA NEW YORK 

Rooms 609 & 610

Engage in strategic discussions about:  

• Advanced API development  

• Tailored one-stop CDMO solutions

• Building global Ecosystems

期待与国际合作伙伴深化协同创新，共同推进医药行业可持续发展。  

We look forward to strengthening global collaboration and co-creating sustainable pharmaceutical breakthroughs.

关于天宇药业

About Tianyu Pharm

天宇药业成立于 1993 年，是一家专业从事高级医药中间体、特色原料药和制剂产品的研发、生产和销售的现代化制药公司，可定制一站式CDMO服务。天宇主要产品涵盖降血压、降血糖、降血脂、抗血栓和抗哮喘药物，是全球主要的心血管类原料药药物制造商之一，沙坦类原料药及中间体全球市场领先。

Tianyu Pharm, founded in 1993, is a modern pharmaceutical company specializing in the research, development, manufacturing, and sales of advanced pharmaceutical intermediates, speciality APIs, formulation products. We also offer one-stop CDMO services to our global partners.Tianyu is the world's leading supplier of chronic disease and anti-cancer drugs, with major products covering blood pressure-lowering, blood glucose-lowering, lipid-lowering, anti-thrombotic and anti-asthma drugs. As one of the world’s leading manufacturers of cardiovascular APIs, Tianyu holds aleading position in the global market for sartans and their intermediates.

E

N

D

（转自：天宇股份）